Koninklijke Philips (PHG) Net Cash Flow Growth (3y) (2012 - 2026)
Koninklijke Philips (PHG) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | 269.22% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | -45.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.70% |
| Mar 31, 2026 | -48.90% |
| Dec 31, 2025 | 30.61% |
| Sep 30, 2025 | 50.15% |
| Jun 30, 2025 | 39.38% |
| Mar 31, 2025 | -67.49% |
| Dec 31, 2024 | 27.88% |
| Sep 30, 2024 | -60.60% |
| Jun 30, 2024 | 27.57% |
| Mar 31, 2024 | -49.12% |
| Dec 31, 2023 | -79.03% |
| Sep 30, 2023 | -7.46% |
| Jun 30, 2023 | -37.41% |
| Mar 31, 2023 | 2.76% |
| Dec 31, 2022 | -86.20% |
| Sep 30, 2022 | -34.96% |
| Jun 30, 2022 | -17.70% |
| Mar 31, 2022 | -162.12% |
| Dec 31, 2021 | -56.52% |
| Sep 30, 2021 | -0.69% |